Most probiotics just pass through. Akkermansia muciniphila AH39 signals your metabolism directly — and in an 8-week human trial, waistlines moved.
Akkermansia lives in the mucus layer that lines your intestine — quietly feeding on mucin and telling your body to rebuild the barrier. Lean, metabolically healthy people tend to carry more of it. People with metabolic stress carry less.
That correlation is why it earned a name most probiotics never will: a next-generation probiotic — and the reason a Shanghai clinical strain house spent years isolating the right strain, not just any Akkermansia.
Tiny share. Outsized job — gut barrier, appetite signals, glucose and lipid balance.
Behind the strain is Shanghai Unibio / HelpLifes — a next-generation probiotics manufacturer that does the unglamorous part: isolation, sequencing, encapsulation and human trials.
To the model strain BAA-835 — this is a characterised Akkermansia, not a mystery culture.
Self-affirmed Generally Recognized As Safe status for use in food.
Microencapsulation engineered to keep live cells alive through stomach acid.
Randomised controlled trial — measured outcomes, not test-tube hope.
AH39 doesn’t “boost” anything vaguely. It uses two surface proteins to send two precise signals.
GLP-1 is the same satiety-and-blood-sugar hormone the whole world is suddenly talking about. AH39 nudges your own gut to make it — through normal biology, not a drug.
A leaky barrier quietly drives metabolic inflammation. Amuc_1100 signals the cells to seal the tight junctions — strengthening the wall from the inside.
Mechanism per manufacturer science (helplifes.com) and published Akkermansia research. Educational — not a medical claim.
In the manufacturer’s human randomised controlled trial of pasteurised AH39, the numbers didn’t whisper.
Average waist-circumference reduction over 8 weeks
−4.27 cm circumference
Lower body-fat percentage
Reduced appetite scores
Lowered AST enzyme
Source: manufacturer human RCT, pasteurised A. muciniphila AH39, 8 weeks, 10B TFU/day (helplifes.com). Outcomes observed in the study population — individual results vary. Dietary supplement; not a treatment for any disease.
Five protective shells carry the live strain past stomach acid and bile — so it arrives in the gut where it can actually do its job.
The manufacturer’s next-generation platform spans far beyond metabolism — the foundation Microbiome Friendly builds its formulas on.
Akkermansia AH39 — clinically studied, 5-layer protected, blended with next-gen and clinical strains. Built into our flagship.
